Low-dose-rate brachytherapy for prostate cancer stands the test of time - the Swiss experience.
BJU Int
; 125(6): 750-751, 2020 06.
Article
in En
| MEDLINE
| ID: mdl-32472665
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Prostatic Neoplasms
/
Brachytherapy
Limits:
Humans
/
Male
Country/Region as subject:
Europa
Language:
En
Journal:
BJU Int
Journal subject:
UROLOGIA
Year:
2020
Document type:
Article
Affiliation country:
Reino Unido
Country of publication:
Reino Unido